Cargando…

Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer

Advanced stages of papillary and anaplastic thyroid cancer continue to be plagued by a dismal prognosis, which is a result of limited effective therapies for these cancers. Due to the high proportion of thyroid cancers harboring mutations in the MAPK pathway, the MAPK pathway has become a focal poin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beadnell, Thomas C., Nassar, Kelsey W., Rose, Madison M., Clark, Erin G., Danysh, Brian P., Hofmann, Marie-Claude, Pozdeyev, Nikita, Schweppe, Rebecca E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833015/ https://www.ncbi.nlm.nih.gov/pubmed/29487290 http://dx.doi.org/10.1038/s41389-017-0015-5

Ejemplares similares

BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer
por: Rose, Madison M., et al.
Publicado: (2023)

Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer
por: Mishall, Katie M., et al.
Publicado: (2017)

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis
por: Kessler, Brittelle E., et al.
Publicado: (2018)

RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
por: Bagheri-Yarmand, Rozita, et al.
Publicado: (2021)

Anaplastic Transformation of Papillary Thyroid Cancer in the Retroperitoneum
por: Solomon, James P., et al.
Publicado: (2015)

Gene master regulators of papillary and anaplastic thyroid cancers
por: Iacobas, Dumitru A., et al.
Publicado: (2017)

ODP497 Multifocal Papillary Thyroid Carcinoma with Anaplastic Dedifferentiation
por: Jacinto, Jorg Jurgen N, et al.
Publicado: (2022)

Metastatic Papillary Thyroid Carcinoma with Multifocal Synchronous Transformation to Anaplastic Thyroid Carcinoma
por: Benedict, Mark, et al.
Publicado: (2016)

Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2019)

The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells()
por: Puli, Oorvashi Roy, et al.
Publicado: (2018)

Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model
por: Danysh, Brian P., et al.
Publicado: (2016)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity
por: Bolf, Eric L., et al.
Publicado: (2023)

SUN-612 Pleural Effusions Revealing Anaplastic Dedifferentiation of Papillary Thyroid Carcinoma
por: Hussain, Qudsia, et al.
Publicado: (2019)

Anaplastic Transformation of Differentiated Papillary Thyroid Carcinoma Presenting as Cauda Equina Syndrome
por: van Griethuysen, Jennifer M., et al.
Publicado: (2021)

Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
por: Nozhat, Zahra, et al.
Publicado: (2018)

Treatment Outcomes in Anaplastic Thyroid Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2019)

Hobnail variant of papillary thyroid carcinoma with anaplastic dedifferentiation co-existent with tuberculosis lymphadenitis
por: Salh, Abdulwahid M., et al.
Publicado: (2021)

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies
por: Pozdeyev, Nikita, et al.
Publicado: (2016)

Squamous Cell Carcinoma of the Thyroid as a Result of Anaplastic Transformation from BRAF-Positive Papillary Thyroid Cancer
por: Basnet, Alina, et al.
Publicado: (2017)

mRNA Expression in Papillary and Anaplastic Thyroid Carcinoma: Molecular Anatomy of a Killing Switch
por: Hébrant, Aline, et al.
Publicado: (2012)

SAT576 Change Is Not Always For The Best! A Transformation of Papillary Into Metastatic Anaplastic Thyroid Carcinoma
por: Syeda, Javeria Nasir, et al.
Publicado: (2023)

Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
por: Pozdeyev, Nikita, et al.
Publicado: (2015)

Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms
por: Davidson, Cole D, et al.
Publicado: (2021)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway
por: Zhang, Peng, et al.
Publicado: (2015)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways
por: Zhang, Jinjun, et al.
Publicado: (2018)

LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway
por: Xu, Debin, et al.
Publicado: (2022)

Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.
por: Takano, T., et al.
Publicado: (1998)

ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma
por: Zhang, Peng, et al.
Publicado: (2023)

Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
por: Nihon-Yanagi, Yasuhiro, et al.
Publicado: (2021)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways: Erratum
por: Zhang, Jinjun, et al.
Publicado: (2023)

SUN-611 A Rare and Interesting Case of Primary Thyroid Lesion as Anaplastic Cancer and Lymph Node Metastasis with Papillary Thyroid Cancer
por: Regeti, Kalyani, et al.
Publicado: (2019)

A case report of anaplastic thyroid cancer and papillary thyroid cancer lymph node metastasis: an unusual presentation as an invasive hypopharyngeal mass
por: Vishwanath, Veena, et al.
Publicado: (2021)

RF11 | PSAT234 Deep learning analysis of thyroid nodule ultrasound images has high sensitivity and negative predictive value to rule-out thyroid cancer
por: Clark, Toshimasa, et al.
Publicado: (2022)

Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis
por: Park, Ji Hye, et al.
Publicado: (2014)

A rare coexistence of papillary carcinoma and anaplastic carcinoma of thyroid in multinodular goitre: Case report and literature review
por: Shahi, Sudha, et al.
Publicado: (2020)

Papillary Thyroid Cancer Differentiating Into Anaplastic Carcinoma With Near-Complete Response to Targeted Dabrafenib/Trametinib Combination Therapy
por: Kulkarni, Pruthali, et al.
Publicado: (2021)

SAT552 Thyroid Mass With Both Anaplastic, Papillary Carcinoma Treated With Surgery, Radiation Therapy, Paclitaxel Chemotherapy
por: Hoang, Thien Huu, et al.
Publicado: (2023)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pktgd5ejbl42cai83a606nfeuv